Hot Products
| Catalog No. | Information |
| CFN00453 | Erucifolin N-oxide |
| CFN00369 | Erucifoline Erucifoline and Jacobine are feeding deterrents and toxic compounds against insect herbivores. |
| CFN98338 | Ervamycine 11-Methoxytabersonine(Ervamycine) exhibits inhibitory effects against five human cancer cell lines , with IC(50) values comparable to those of cisplatin and vinorelbine. |
| CFN97096 | Erythrinin C Standard reference |
| CFN98351 | Erythristemine (+)-Erythristemine shows moderate toxicity to brine shrimp (LC50 23 ppm) and moderate (IC50=86microg/ml) radical scavenging properties against stable 2,2-diphenyl-1-picrylhy--drazyl (DPPH) radical. |
| CFN99620 | Erythritol Erythritol is a biological sweetener with applications in food and pharmaceutical industries, it is also used as a functional sugar substitute in special foods for people with diabetes and obesity because of its unique nutritional properties. Erythritol consumption acutely improved small vessel endothelial function, and chronic treatment reduced central aortic stiffness, may be as a preferred sugar substitute for patients with diabetes mellitus. |
| CFN98914 | Erythrodiol Erythrodiol is the precursor of pentacyclic triterpenic acids, it exerts antiproliferative and proapoptotic activity in colon adenocarcinoma cells. Erythrodiol may have interesting therapeutic potential as new vasodilator drugs, thus protecting the cardiovascular system. |
| CFN95416 | Erythro-Guaiacylglycerol-beta-coniferyl aldehyde ether Erythro-Guaiacylglycerol-beta-coniferyl aldehyde ether,cytotoxic effects on human cancer cell lines |
| CFN95363 | Eschweilenol C Eschweilenol C has antifungal, anti-inflammatory, antioxidant, antidiabetic activity. 4-(alpha-rhamnopyranosyl)ellagic acid is an inhibitor of human recombinant aldose reductase HRAR (IC50 = 4.1 x 10(-8) M). |
| CFN93368 | Escin IA Escin IA is a prodrug and its structure can be converted to desacylescin I by human intestinal bacteria and Lactobacillus brevis., desacylescin I as a biotransformation product shows potentially inhibitory effects on mouse tumor, and a potential candidate for anti tumor agents. Escin IA has anti-TNBC metastasis activity, and its action mechanisms involved inhibition of EMT process by down-regulating LOXL2 expression. |
